GleamWall
中文EN

HSCS HeartSciences Inc.

Finance Services · Nasdaq · SEC CIK 1468492 · Fiscal year ends 04/30

Financial factors as of 2026-07-31 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-17.0%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin60.9%
Operating margin-209,733.1%
Net margin-227,024.2%
FCF margin—
EBITDA margin-209,135.3%

Returns

ROE-1,851.9%
ROA-201.7%
ROIC (approx.)—
Asset turnover0.00x

Leverage & solvency

Liabilities / assets154.4%
Debt / equity—
Current ratio0.14x
Interest coverage-11.78x

Cash quality & payout

Operating cash flow / net income0.66x
Accruals ratio-68.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-07-312026Q4*2026-04-302026Q32026-01-312025Q22025-10-312025Q12025-07-312025Q4*2025-04-302025Q32025-01-312025Q22024-10-31
Income statement
Revenue$2,100$0$0$2,419$1,900$4,350$0—
Cost of revenue$760$0$0$1,008$760$1,880$0—
Gross profit$1,340$0$0$1,411$1,140$2,470$0—
R&D expense$906,629$476,205$638,575$727,026$997,206$929,091$1.03M$1.20M
SG&A expense$2.03M$2.06M$1.29M$1.35M$878,053$993,778$1.34M$786,068
Operating income-$2.94M-$2.54M-$1.93M-$2.07M-$1.87M-$1.92M-$2.37M-$1.99M
Interest expense$235,261$228,310$61,509$279,534$183,688$180,852$179,477$117,598
Net income-$3.17M-$2.75M-$1.99M-$2.35M-$2.05M-$2.09M-$2.54M-$2.08M
EBITDA-$2.93M-$2.53M-$1.92M-$2.07M-$1.87M-$1.91M-$2.37M-$1.97M
EPS (basic)-0.86—-0.63-0.85-1.58—-2.57-2.27
EPS (diluted)———-0.85-1.58—-2.57-2.27
Dividends declared per share0.000.00——————
Weighted avg. shares (diluted)———2.78M1.30M—986,057917,445
Balance sheet
Cash & equivalents$29,906$1.66M$3.40M$1.95M$2.79M$1.10M$2.60M$4.05M
Receivables——$0——$4,350——
Inventory$402,989$655,629$657,285$657,285$649,507$650,267$652,147$652,907
Current assets$811,768$2.58M$5.10M$3.79M$4.42M$2.17M$3.63M$5.69M
PP&E, net$32,980$39,312$46,070$52,986$56,438$63,549$71,062$77,069
Intangibles$1.66M$1.66M$1.66M$1.63M$1.62M$1.62M$1.61M$1.59M
Total assets$3.74M$5.26M$7.55M$6.00M$6.44M$4.22M$5.70M$7.78M
Current liabilities$5.63M$4.86M$4.27M$1.57M$3.01M$3.70M$3.57M$3.30M
Total liabilities$5.77M$5.04M$4.90M$1.81M$3.30M$4.02M$3.92M$3.76M
Shareholders' equity-$2.03M$226,060$2.65M$4.18M$3.14M$205,171$1.79M$4.02M
Shares outstanding3.90M3.19M3.18M3.07M2.28M1.12M1.03M947,821
Cash flow statement
Operating cash flow-$1.32M-$1.68M-$1.46M-$2.33M-$1.95M-$1.59M-$1.62M-$2.18M
Capital expenditure—$0-$9,476——$0$0—
Free cash flow—-$1.68M-$1.45M——-$1.59M-$1.62M—
Investing cash flow-$280,107$0-$27,868-$15,770-$814-$7,812-$15,701-$5,842
Financing cash flow-$27,942-$63,673$2.94M$1.51M$3.65M$100,028$180,187$1.90M
Depreciation & amortization$6,332$6,758$6,916$7,006$7,111$7,513$6,007$12,215
Stock-based compensation$738,889$324,841$376,100$436,884$174,558$95,945$54,824$44,561

Free plan shows the latest 8 periods; Pro shows all 21 🔒

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.